LogicBio Therapeutics, Inc. Made Big Gain

Mon, May 09, 2022 at 05:35 PM
LogicBio Therapeutics, Inc. Made Big Gain

LogicBio Therapeutics, Inc. (LOGC:NASDAQ) shot up at $0.67, representing a gain of 34.3%. The stock got featured on our News Catalysts scanner on Mon, May 09, 2022 at 12:07 PM in the 'BIOTECH' category. From Mon, Apr 25, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days

About LogicBio Therapeutics, Inc. (LOGC:NASDAQ)

LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, its proprietary technology platform.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.